Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Arruga

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Purinergic Signalling|July 17, 2021
ENTPD5 splice variants: novel players in cancer?Francesca Arruga
Handbook of Experimental Pharmacology|March 10, 2017
Mechanisms of Resistance to Targeted Therapies in Chronic Lymphocytic LeukemiaFrancesca Arruga, Silvia Deaglio
International Journal of Molecular Sciences|April 13, 2018
Targeting the Adenosinergic Axis in Chronic Lymphocytic Leukemia: A Way to Disrupt the Tumor Niche?Tiziana Vaisitti, Francesca Arruga, Silvia Deaglio
Cancers|September 9, 2020
Chronic Lymphocytic LeukemiaTiziana Vaisitti, Francesca Arruga, Alessandra Ferrajoli
Frontiers in Oncology|December 12, 2018
The NOTCH Pathway and Its Mutations in Mature B Cell MalignanciesFrancesca Arruga, Tiziana Vaisitti, Silvia Deaglio
Frontiers in Immunology|October 23, 2019
Ectonucleotidases in Blood Malignancies: A Tale of Surface Markers and Therapeutic TargetsTiziana Vaisitti, Francesca Arruga, Giulia Guerra, et al.
International Journal of Molecular Sciences|March 12, 2020
Immune Response Dysfunction in Chronic Lymphocytic Leukemia: Dissecting Molecular Mechanisms and Microenvironmental ConditionsFrancesca Arruga, Benjamin Baffour Gyau, Andrea Iannello, et al.
Blood|March 5, 2004
Usefulness of the quantitative assessment of PRV-1 gene expression for the diagnosis of polycythemia vera and essential thrombocythemia patientsDaniela Cilloni, Sonia Carturan, Enrico Gottardi, et al.
Annals of the New York Academy of Sciences|January 15, 2005
Myelodysplastic syndromesDaniela Cilloni, Francesca Messa, Sonia Carturan, et al.
Current Topics in Medicinal Chemistry|November 1, 2013
Multiple metamorphoses of CD38 from prognostic marker to disease modifier to therapeutic target in chronic lymphocytic leukemiaTiziana Vaisitti, Valentina Audrito, Sara Serra, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Purinergic Signalling|July 17, 2021
ENTPD5 splice variants: novel players in cancer?Francesca Arruga
Handbook of Experimental Pharmacology|March 10, 2017
Mechanisms of Resistance to Targeted Therapies in Chronic Lymphocytic LeukemiaFrancesca Arruga, Silvia Deaglio
International Journal of Molecular Sciences|April 13, 2018
Targeting the Adenosinergic Axis in Chronic Lymphocytic Leukemia: A Way to Disrupt the Tumor Niche?Tiziana Vaisitti, Francesca Arruga, Silvia Deaglio
Cancers|September 9, 2020
Chronic Lymphocytic LeukemiaTiziana Vaisitti, Francesca Arruga, Alessandra Ferrajoli
Frontiers in Oncology|December 12, 2018
The NOTCH Pathway and Its Mutations in Mature B Cell MalignanciesFrancesca Arruga, Tiziana Vaisitti, Silvia Deaglio
Frontiers in Immunology|October 23, 2019
Ectonucleotidases in Blood Malignancies: A Tale of Surface Markers and Therapeutic TargetsTiziana Vaisitti, Francesca Arruga, Giulia Guerra, et al.
International Journal of Molecular Sciences|March 12, 2020
Immune Response Dysfunction in Chronic Lymphocytic Leukemia: Dissecting Molecular Mechanisms and Microenvironmental ConditionsFrancesca Arruga, Benjamin Baffour Gyau, Andrea Iannello, et al.
Blood|March 5, 2004
Usefulness of the quantitative assessment of PRV-1 gene expression for the diagnosis of polycythemia vera and essential thrombocythemia patientsDaniela Cilloni, Sonia Carturan, Enrico Gottardi, et al.
Annals of the New York Academy of Sciences|January 15, 2005
Myelodysplastic syndromesDaniela Cilloni, Francesca Messa, Sonia Carturan, et al.
Current Topics in Medicinal Chemistry|November 1, 2013
Multiple metamorphoses of CD38 from prognostic marker to disease modifier to therapeutic target in chronic lymphocytic leukemiaTiziana Vaisitti, Valentina Audrito, Sara Serra, et al.
Pageof 5